Schrodinger
Schrodinger Inc is an American computational software and biotechnology enterprise headquartered in New York City, New York. The company specializes in developing advanced physics-based molecular modeling software platforms utilized by pharmaceutical and biotechnology R&D organizations to discover novel drug candidates and materials. Additionally, Schrödinger maintains an internal pipeline of therapeutic discovery programs. Principal revenue is derived through annual software license subscriptions and collaborative pharmaceutical research milestone payments. Schrödinger Inc is publicly listed on the Nasdaq Stock Market.
2 of the funds FundTelligence covers report a position in Schrodinger.
- Legal name
- SCHRODINGER INC
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 2
- Exposure themes
- Artificial Intelligence, Drug Discovery & Design, Healthcare
Funds holding Schrodinger
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.18 % (full portfolio disclosed, October 2026)
- Mercer Global Small Cap Equity Fund — Mercer · 0.09 % (full portfolio disclosed, December 2025)